Global Transdermal Drug Patches Market Research Report 2023(Status and Outlook)

Global Transdermal Drug Patches Market Research Report 2023(Status and Outlook)



Report Overview

Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.

The major players in global Transdermal Drug Patches market include Hisamitsu Pharmaceutical, Johnson & Johnson, Mylan, etc. The top 3 players occupy about 35% shares of the global market. America and Europe are main markets, they occupy about 75% of the global market. Methyl Salicylate-based Patch is the main type, with a share over 15%. Rx Channel is the main application, which holds a share about 90%.

The Global Transdermal Drug Patches Market Size was estimated at USD 6181.00 million in 2022 and is projected to reach USD 7758.20 million by 2029, exhibiting a CAGR of 3.30% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Transdermal Drug Patches market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Transdermal Drug Patches Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Transdermal Drug Patches market in any manner.

Global Transdermal Drug Patches Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Hisamitsu Pharmaceutical

Johnson & Johnson

Novartis

UCB Pharma

Mylan

Teva Pharmaceutical

Nitto Denko

Grünenthal

IBSA Group

GSK

Luye Pharma Group

Pfizer

Chattem

Dr Reddy’s Laboratories

Bayer

Mundipharma

Endo International

Beijing Tide Pharmaceutical

Market Segmentation (by Type)

Methyl Salicylate-based Patch

Rivastigmine Transdermal Patch

Fentanyl Transdermal Patch

Lidocaine Patch

Diclofenac Patch

Nicotine Transdermal Patch

Others

Market Segmentation (by Application)

Commercial

Household

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Transdermal Drug Patches Market

Overview of the regional outlook of the Transdermal Drug Patches Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Transdermal Drug Patches
1.2 Key Market Segments
1.2.1 Transdermal Drug Patches Segment by Type
1.2.2 Transdermal Drug Patches Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Transdermal Drug Patches Market Overview
2.1 Global Market Overview
2.1.1 Global Transdermal Drug Patches Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Transdermal Drug Patches Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Transdermal Drug Patches Market Competitive Landscape
3.1 Global Transdermal Drug Patches Sales by Manufacturers (2018-2023)
3.2 Global Transdermal Drug Patches Revenue Market Share by Manufacturers (2018-2023)
3.3 Transdermal Drug Patches Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Transdermal Drug Patches Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Transdermal Drug Patches Sales Sites, Area Served, Product Type
3.6 Transdermal Drug Patches Market Competitive Situation and Trends
3.6.1 Transdermal Drug Patches Market Concentration Rate
3.6.2 Global 5 and 10 Largest Transdermal Drug Patches Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Transdermal Drug Patches Industry Chain Analysis
4.1 Transdermal Drug Patches Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Transdermal Drug Patches Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Transdermal Drug Patches Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Transdermal Drug Patches Sales Market Share by Type (2018-2023)
6.3 Global Transdermal Drug Patches Market Size Market Share by Type (2018-2023)
6.4 Global Transdermal Drug Patches Price by Type (2018-2023)
7 Transdermal Drug Patches Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Transdermal Drug Patches Market Sales by Application (2018-2023)
7.3 Global Transdermal Drug Patches Market Size (M USD) by Application (2018-2023)
7.4 Global Transdermal Drug Patches Sales Growth Rate by Application (2018-2023)
8 Transdermal Drug Patches Market Segmentation by Region
8.1 Global Transdermal Drug Patches Sales by Region
8.1.1 Global Transdermal Drug Patches Sales by Region
8.1.2 Global Transdermal Drug Patches Sales Market Share by Region
8.2 North America
8.2.1 North America Transdermal Drug Patches Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Transdermal Drug Patches Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Transdermal Drug Patches Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Transdermal Drug Patches Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Transdermal Drug Patches Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Hisamitsu Pharmaceutical
9.1.1 Hisamitsu Pharmaceutical Transdermal Drug Patches Basic Information
9.1.2 Hisamitsu Pharmaceutical Transdermal Drug Patches Product Overview
9.1.3 Hisamitsu Pharmaceutical Transdermal Drug Patches Product Market Performance
9.1.4 Hisamitsu Pharmaceutical Business Overview
9.1.5 Hisamitsu Pharmaceutical Transdermal Drug Patches SWOT Analysis
9.1.6 Hisamitsu Pharmaceutical Recent Developments
9.2 Johnson andamp; Johnson
9.2.1 Johnson andamp; Johnson Transdermal Drug Patches Basic Information
9.2.2 Johnson andamp; Johnson Transdermal Drug Patches Product Overview
9.2.3 Johnson andamp; Johnson Transdermal Drug Patches Product Market Performance
9.2.4 Johnson andamp; Johnson Business Overview
9.2.5 Johnson andamp; Johnson Transdermal Drug Patches SWOT Analysis
9.2.6 Johnson andamp; Johnson Recent Developments
9.3 Novartis
9.3.1 Novartis Transdermal Drug Patches Basic Information
9.3.2 Novartis Transdermal Drug Patches Product Overview
9.3.3 Novartis Transdermal Drug Patches Product Market Performance
9.3.4 Novartis Business Overview
9.3.5 Novartis Transdermal Drug Patches SWOT Analysis
9.3.6 Novartis Recent Developments
9.4 UCB Pharma
9.4.1 UCB Pharma Transdermal Drug Patches Basic Information
9.4.2 UCB Pharma Transdermal Drug Patches Product Overview
9.4.3 UCB Pharma Transdermal Drug Patches Product Market Performance
9.4.4 UCB Pharma Business Overview
9.4.5 UCB Pharma Transdermal Drug Patches SWOT Analysis
9.4.6 UCB Pharma Recent Developments
9.5 Mylan
9.5.1 Mylan Transdermal Drug Patches Basic Information
9.5.2 Mylan Transdermal Drug Patches Product Overview
9.5.3 Mylan Transdermal Drug Patches Product Market Performance
9.5.4 Mylan Business Overview
9.5.5 Mylan Transdermal Drug Patches SWOT Analysis
9.5.6 Mylan Recent Developments
9.6 Teva Pharmaceutical
9.6.1 Teva Pharmaceutical Transdermal Drug Patches Basic Information
9.6.2 Teva Pharmaceutical Transdermal Drug Patches Product Overview
9.6.3 Teva Pharmaceutical Transdermal Drug Patches Product Market Performance
9.6.4 Teva Pharmaceutical Business Overview
9.6.5 Teva Pharmaceutical Recent Developments
9.7 Nitto Denko
9.7.1 Nitto Denko Transdermal Drug Patches Basic Information
9.7.2 Nitto Denko Transdermal Drug Patches Product Overview
9.7.3 Nitto Denko Transdermal Drug Patches Product Market Performance
9.7.4 Nitto Denko Business Overview
9.7.5 Nitto Denko Recent Developments
9.8 Grünenthal
9.8.1 Grünenthal Transdermal Drug Patches Basic Information
9.8.2 Grünenthal Transdermal Drug Patches Product Overview
9.8.3 Grünenthal Transdermal Drug Patches Product Market Performance
9.8.4 Grünenthal Business Overview
9.8.5 Grünenthal Recent Developments
9.9 IBSA Group
9.9.1 IBSA Group Transdermal Drug Patches Basic Information
9.9.2 IBSA Group Transdermal Drug Patches Product Overview
9.9.3 IBSA Group Transdermal Drug Patches Product Market Performance
9.9.4 IBSA Group Business Overview
9.9.5 IBSA Group Recent Developments
9.10 GSK
9.10.1 GSK Transdermal Drug Patches Basic Information
9.10.2 GSK Transdermal Drug Patches Product Overview
9.10.3 GSK Transdermal Drug Patches Product Market Performance
9.10.4 GSK Business Overview
9.10.5 GSK Recent Developments
9.11 Luye Pharma Group
9.11.1 Luye Pharma Group Transdermal Drug Patches Basic Information
9.11.2 Luye Pharma Group Transdermal Drug Patches Product Overview
9.11.3 Luye Pharma Group Transdermal Drug Patches Product Market Performance
9.11.4 Luye Pharma Group Business Overview
9.11.5 Luye Pharma Group Recent Developments
9.12 Pfizer
9.12.1 Pfizer Transdermal Drug Patches Basic Information
9.12.2 Pfizer Transdermal Drug Patches Product Overview
9.12.3 Pfizer Transdermal Drug Patches Product Market Performance
9.12.4 Pfizer Business Overview
9.12.5 Pfizer Recent Developments
9.13 Chattem
9.13.1 Chattem Transdermal Drug Patches Basic Information
9.13.2 Chattem Transdermal Drug Patches Product Overview
9.13.3 Chattem Transdermal Drug Patches Product Market Performance
9.13.4 Chattem Business Overview
9.13.5 Chattem Recent Developments
9.14 Dr Reddy’s Laboratories
9.14.1 Dr Reddy’s Laboratories Transdermal Drug Patches Basic Information
9.14.2 Dr Reddy’s Laboratories Transdermal Drug Patches Product Overview
9.14.3 Dr Reddy’s Laboratories Transdermal Drug Patches Product Market Performance
9.14.4 Dr Reddy’s Laboratories Business Overview
9.14.5 Dr Reddy’s Laboratories Recent Developments
9.15 Bayer
9.15.1 Bayer Transdermal Drug Patches Basic Information
9.15.2 Bayer Transdermal Drug Patches Product Overview
9.15.3 Bayer Transdermal Drug Patches Product Market Performance
9.15.4 Bayer Business Overview
9.15.5 Bayer Recent Developments
9.16 Mundipharma
9.16.1 Mundipharma Transdermal Drug Patches Basic Information
9.16.2 Mundipharma Transdermal Drug Patches Product Overview
9.16.3 Mundipharma Transdermal Drug Patches Product Market Performance
9.16.4 Mundipharma Business Overview
9.16.5 Mundipharma Recent Developments
9.17 Endo International
9.17.1 Endo International Transdermal Drug Patches Basic Information
9.17.2 Endo International Transdermal Drug Patches Product Overview
9.17.3 Endo International Transdermal Drug Patches Product Market Performance
9.17.4 Endo International Business Overview
9.17.5 Endo International Recent Developments
9.18 Beijing Tide Pharmaceutical
9.18.1 Beijing Tide Pharmaceutical Transdermal Drug Patches Basic Information
9.18.2 Beijing Tide Pharmaceutical Transdermal Drug Patches Product Overview
9.18.3 Beijing Tide Pharmaceutical Transdermal Drug Patches Product Market Performance
9.18.4 Beijing Tide Pharmaceutical Business Overview
9.18.5 Beijing Tide Pharmaceutical Recent Developments
10 Transdermal Drug Patches Market Forecast by Region
10.1 Global Transdermal Drug Patches Market Size Forecast
10.2 Global Transdermal Drug Patches Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Transdermal Drug Patches Market Size Forecast by Country
10.2.3 Asia Pacific Transdermal Drug Patches Market Size Forecast by Region
10.2.4 South America Transdermal Drug Patches Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Transdermal Drug Patches by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Transdermal Drug Patches Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Transdermal Drug Patches by Type (2024-2029)
11.1.2 Global Transdermal Drug Patches Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Transdermal Drug Patches by Type (2024-2029)
11.2 Global Transdermal Drug Patches Market Forecast by Application (2024-2029)
11.2.1 Global Transdermal Drug Patches Sales (K MT) Forecast by Application
11.2.2 Global Transdermal Drug Patches Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings